Wealthfront Advisers LLC bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 81,183 shares of the health services provider's stock, valued at approximately $2,696,000. Wealthfront Advisers LLC owned 0.05% of Teladoc Health as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. DB Wealth Management Group LLC acquired a new position in Teladoc Health during the first quarter worth $25,000. McCarthy Asset Management Inc. acquired a new position in Teladoc Health during the first quarter worth $25,000. Oliver Lagore Vanvalin Investment Group acquired a new position in Teladoc Health during the first quarter worth $27,000. City State Bank acquired a new position in Teladoc Health during the fourth quarter worth $27,000. Finally, GoalVest Advisory LLC acquired a new position in Teladoc Health during the first quarter worth $31,000. Institutional investors and hedge funds own 92.46% of the company's stock.
Get Teladoc Health alerts:Analyst Upgrades and Downgrades
TDOC has been the topic of several research reports. Truist Financial initiated coverage on shares of Teladoc Health in a report on Wednesday, September 7th. They set a "hold" rating and a $35.00 price objective on the stock. Piper Sandler lowered their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, July 28th. Royal Bank of Canada lowered their target price on shares of Teladoc Health from $53.00 to $35.00 in a report on Wednesday. Cowen downgraded shares of Teladoc Health from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $58.00 to $34.00 in a report on Tuesday, August 2nd. Finally, Stifel Nicolaus lowered their target price on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. Two analysts have rated the stock with a sell rating, twenty-four have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $64.13.
Insider Buying and Selling
In related news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $30.18, for a total transaction of $30,180.00. Following the sale, the senior vice president now owns 25,408 shares of the company's stock, valued at approximately $766,813.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $30.18, for a total transaction of $30,180.00. Following the sale, the senior vice president now owns 25,408 shares of the company's stock, valued at approximately $766,813.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the completion of the transaction, the insider now directly owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,318 shares of company stock valued at $255,321. Company insiders own 1.55% of the company's stock.Teladoc Health Stock Down 3.4 %
TDOC stock opened at $25.35 on Friday. The firm has a 50 day moving average of $33.43 and a 200-day moving average of $41.33. Teladoc Health, Inc. has a 12 month low of $25.33 and a 12 month high of $156.82. The company has a debt-to-equity ratio of 0.25, a quick ratio of 3.22 and a current ratio of 3.38.
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.71) by $0.27. The business had revenue of $592.38 million for the quarter, compared to analyst estimates of $586.86 million. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. Equities analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current fiscal year.
About Teladoc Health
(Get Rating)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Featured Articles
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Thor Industries Hammers Out A Bottom
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.